{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-156113","form_type":"8-K","ticker":"SLNO","cik":"0001484565","company_name":"SOLENO THERAPEUTICS INC","filed_at":"2024-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.611714+00:00","generated_at":"2026-06-01T05:52:35.231475+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Soleno shareholders elect director, ratify auditor, and approve expanded equity incentive plan","bullets":["Andrew Sinclair elected as Class I director with 93.3% of votes cast (26.4M for, 1.9M withheld).","Marcum LLP ratified as independent auditor for FY 2024 (29.2M for, 135K against).","Amended 2014 Equity Incentive Plan approved (19.4M for, 8.9M against); share pool set at 5,825,762 shares plus annual 4% evergreen increase.","Voter turnout of 87.7% (29,312,453 of 33,411,329 shares outstanding)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-156113","json":"https://secwatch.observer/filing/0001193125-24-156113.json","markdown":"https://secwatch.observer/filing/0001193125-24-156113.md","text":"https://secwatch.observer/filing/0001193125-24-156113.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484565/000119312524156113/0001193125-24-156113-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484565/000119312524156113/d834951d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:52:35.231475+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}